Estimated pre-morbid IQ effects on cognitive and functional outcomes in Alzheimer disease: a longitudinal study in a treated cohort.

Full Abstract

BACKGROUND:
Cognitive reserve is thought to influence the degree of neuropathology needed for diagnosis of Alzheimer disease (AD). Cognitive reserve can be operationally defined as the hypothesized capacity of the mature adult brain to sustain the effects of disease or injury without manifesting clinical symptoms of AD, but sufficient to cause clinical dementia in an individual possessing less cognitive reserve. Its effect on the subsequent course of AD is less clear. Pre-morbid IQ is a useful measure of cognitive reserve.

METHODS:
We studied 659 consecutive patients with AD at a tertiary referral memory clinic. Patients were assessed on six cognitive tests at baseline. Activities of Daily Living (ADL) were measured on the Instrumental Activities of Daily Living (IADL) scale and Physical Self-Maintenance Scale (PSMS). The National Adult Reading Test (NART) was used to estimate pre-morbid IQ. Patients were followed up after starting a cholinesterase inhibitor over 78 weeks. Mixed general linear models estimated the effects of NART on cognition and ADL.

RESULTS:
Three hundred and fifty-five patients had NART scored with a mean estimated pre-morbid IQ of 104.7 (standard deviation 18.5). NART increased overall cognitive ability by 2.7% for every 10 IQ points (p < .001). There was a trend for an effect on the change in cognition over time (p = .065) with higher NART associated with improvement of cognitive ability over time. After adjusting for age and sex, a 10 point increase in NART was associated with an improvement of 2% in ADL scores, but this effect was explained by NART's influence on contemporaneous cognitive ability.

CONCLUSION:
Our data support the hypothesis that cognitive reserve continues to have a limited influence on cognition after AD has been diagnosed and thus, indirectly, has an impact on ADL.

Learn Faster Today Improve your study skills

Author information

Author/s: Starr, John M (JM); Lonie, Jane (J);

Affiliation: Geriatric Medicine unit, University of Edinburgh, Craigleith Road, Edinburgh, UK. jstarr@staffmail.ed.ac.uk

Journal and publication information

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal: BMC psychiatry (BMC Psychiatry), published in England. (Language: eng)

Reference: 2008-; vol 8 (issue ) : pp 27

Dates: Created 2008/05/09; Completed 2008/08/06;

PMID: 18426581, status: MEDLINE (last retrieval date: 11/6/2008)

Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.

External Links for this article (including full text providers, if available):

Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.

This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.

MeSH headings (categories)

This article was linked to the MESH Headings shown below.

Activities of Daily Living
Aged
Alzheimer Disease - drug therapy; psychology
Cognition
Female
Follow-Up Studies
Humans
Indans - therapeutic use
Intelligence
Intelligence Tests
Learning

Longitudinal Studies
Male
Neuroprotective Agents - therapeutic use
Nootropic Agents - therapeutic use
Patient Compliance
Phenylcarbamates - therapeutic use
Piperidines - therapeutic use
Prognosis
Reading
Self Care
Speech

Associated Chemicals: Indans (0) ; Neuroprotective Agents (0) ; Nootropic Agents (0) ; Phenylcarbamates (0) ; Piperidines (0) ; donepezil (120011-70-3) ; rivastigmine (123441-03-2)

These are the highest related articles currently in the database:

See 100+ related articles.